InvestorsHub Logo
Followers 62
Posts 7548
Boards Moderated 1
Alias Born 01/02/2003

Re: Sam81 post# 60237

Thursday, 10/01/2015 10:51:01 AM

Thursday, October 01, 2015 10:51:01 AM

Post# of 425795
Sam: I still have the naive belief that the law attempts to be fair and equitable. In the case of Vascepa NCE, the exclusivity denial(later reversed) has deprived Amarin of much of the benefits intended in the H-W statute. While the statute does not specifically address the situation of Vascepa, nevertheless an equitable solution requires some redress.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News